Harrow, Inc. Shares Outstanding (Cover Page)
Harrow, Inc. (HROW) had Shares Outstanding (Cover Page) of 37.49 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-06: Entity Common Stock, Shares Outstanding 37.49M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 37.28M shares.
- 2026-02-25: Entity Common Stock, Shares Outstanding 37.23M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 37.04M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 37.49M shares 10-Q · filed 2026-08-10 |
| 2026-05-06 | 37.28M shares 10-Q · filed 2026-05-11 |
| 2026-02-25 | 37.23M shares 10-K · filed 2026-03-02 |
| 2025-11-10 | 37.04M shares 10-Q · filed 2025-11-10 |
| 2025-08-08 | 37.00M shares 10-Q · filed 2025-08-11 |
| 2025-05-07 | 36.70M shares 10-Q · filed 2025-05-08 |
| 2025-03-26 | 35.65M shares 10-K · filed 2025-03-27 |
| 2024-11-12 | 35.61M shares 10-Q · filed 2024-11-14 |
| 2024-08-07 | 35.48M shares 10-Q · filed 2024-08-07 |
| 2024-05-10 | 35.38K shares 10-Q · filed 2024-05-13 |
| 2024-03-18 | 35.36M shares 10-K · filed 2024-03-19 |
| 2023-11-13 | 35.12M shares 10-Q · filed 2023-11-13 |
| 2023-08-09 | 35.12M shares 10-Q · filed 2023-08-09 |
| 2023-05-10 | 30.12M shares 10-Q · filed 2023-05-11 |
| 2023-03-22 | 29.97M shares 10-K · filed 2023-03-23 |
| 2022-11-11 | 27.41M shares 10-Q · filed 2022-11-14 |
| 2022-08-08 | 27.07M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 27.03M shares 10-Q · filed 2022-05-05 |
| 2022-03-08 | 27.03M shares 10-K · filed 2022-03-10 |
| 2021-11-08 | 26.90M shares 10-Q · filed 2021-11-09 |
| 2021-08-09 | 26.89M shares 10-Q · filed 2021-08-10 |
| 2021-05-10 | 26.58M shares 10-Q · filed 2021-05-11 |
| 2021-03-08 | 25.98M shares 10-K · filed 2021-03-08 |
| 2020-11-06 | 25.75M shares 10-Q · filed 2020-11-09 |
| 2020-08-07 | 25.65M shares 10-Q · filed 2020-08-10 |
| 2020-05-08 | 25.62M shares 10-Q · filed 2020-05-11 |
| 2020-03-12 | 25.53M shares 10-K · filed 2020-03-13 |
| 2019-11-12 | 25.17M shares 10-Q · filed 2019-11-13 |
| 2019-08-13 | 25.17M shares 10-Q · filed 2019-08-14 |
| 2019-05-08 | 24.72M shares 10-Q · filed 2019-05-09 |
| 2019-03-11 | 24.69M shares 10-K · filed 2019-03-12 |
| 2018-11-12 | 23.28M shares 10-Q · filed 2018-11-13 |
| 2018-08-03 | 21.05M shares 10-Q · filed 2018-08-06 |
| 2018-05-14 | 20.88M shares 10-Q · filed 2018-05-15 |
| 2018-03-07 | 20.78M shares 10-K · filed 2018-03-08 |
| 2017-11-13 | 20.54M shares 10-Q · filed 2017-11-14 |
| 2017-08-09 | 20.07M shares 10-Q · filed 2017-08-10 |
| 2017-05-09 | 20.07M shares 10-Q · filed 2017-05-10 |
| 2017-03-20 | 18.63M shares 10-K · filed 2017-03-21 |
| 2016-11-11 | 13.25M shares 10-Q · filed 2016-11-14 |
| 2016-08-12 | 13.18M shares 10-Q · filed 2016-08-15 |
| 2016-05-11 | 13.31M shares 10-Q · filed 2016-05-12 |
| 2016-03-22 | 13.11M shares 10-K · filed 2016-03-23 |
| 2015-11-11 | 9.68M shares 10-Q · filed 2015-11-12 |
| 2015-08-11 | 9.59M shares 10-Q · filed 2015-08-12 |
| 2015-05-12 | 9.55M shares 10-Q · filed 2015-05-13 |
| 2015-03-11 | 9.34M shares 10-K · filed 2015-03-12 |
| 2014-11-11 | 9.26M shares 10-Q · filed 2014-11-12 |
| 2014-08-12 | 9.13M shares 10-Q · filed 2014-08-13 |
| 2014-03-27 | 9.09M shares 10-Q · filed 2014-05-15 |
| 2013-11-05 | 8.97M shares 10-Q · filed 2013-11-06 |
| 2013-08-13 | 8.96M shares 10-Q · filed 2013-08-14 |
| 2013-05-07 | 8.89M shares 10-Q · filed 2013-05-08 |
| 2013-03-15 | 8.89M shares 10-K · filed 2013-03-18 |
| 2012-09-30 | 33.86M shares 10-Q · filed 2012-11-14 |
| 2012-08-14 | 29.70M shares 10-Q · filed 2012-08-14 |
| 2012-05-09 | 22.20M shares 10-Q · filed 2012-05-10 |
| 2012-02-23 | 15.90M shares 10-K · filed 2012-02-23 |
| 2012-02-22 | 15.90M shares 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |